Please assess the completion status of the following clinical trial:

Trial Title: Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years or more~* COVID-19 confirmed by PCR~* Oxygen requirements until 35 % by venturi mask or 5 lt minutes by nasal cannula~* Consent form signed~Exclusion Criteria:~* Previous steroid use 48 hours or more.~* Pregnancy~* Chronic respiratory failure~* Requirements of mechanical ventilation (invasive or no invasive)~* Chronic liver damage Child Pugh B or C~* Chronic kidney disease stage IV or V.~* Immunosuppressed~* Participation on other trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Prednisone 40 mg days 1 to 4. Then Prednisone 20 mg days 5 to 8.
- Control (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).